Skip to content
PeptideRank

Provider review

Direct Meds review

Real flat prices for all three boarded compounds — no pharmacy named anywhere.

Direct Meds' own product pages state a single flat price for tirzepatide ($399/mo), semaglutide ($297/mo), and sermorelin (sold as "Sermorix," $199/mo), each repeated beside "No Monthly Memberships, No Hidden Fees, Cancel Anytime." No pharmacy is named anywhere on the site, and no public Terms of Service page exists at any path checked.

Verified August 2026

Transparency scorecard

2 of 4 disclosed openly

What Direct Meds discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Disclosed

The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.

This review's stake, stated plainly some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

What it actually costs

High confidence

What they advertise

Direct Meds' own product pages state one flat figure per compound: "$399/month, $9.58 per day" (tirzepatide), "$297/month, $9.58 per day" (semaglutide), and "$199/month, $6.42 per day" (sermorelin/"Sermorix") — each repeated beside "No Monthly Memberships, No Hidden Fees, Cancel Anytime."

What you actually pay, month to month

$399/month (tirzepatide), $297/month (semaglutide), and $199/month (sermorelin) ARE the standing prices on every product page checked — no separate one-time SKU, prepay tier, or auto-refill discount was found contradicting them. Its own FAQ separately mentions a lower, unconfirmed figure for a "sublingual Semaglutide" format not found as its own page on the live site.

Checked live on Direct Meds's own site at https://directmeds.com/products/tirzepatide in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off Direct Meds's own public pages on the date shown, not from a third-party comparison table.

The bottom line

Direct Meds (directmeds.com) is a real, live telehealth platform selling compounded tirzepatide, compounded semaglutide, and compounded sermorelin (under its own product brand, "Sermorix"), alongside a broader non-GLP-1 catalog. Its pricing is genuinely clean by this roster's standards: each product page states one flat monthly figure, matches its own FAQ where checked, and carries an explicit, repeated no-subscription claim with no prepay tier or auto-refill mechanism found anywhere. What pulls the picture down: no pharmacy is named on any page (only generic "licensed compounding pharmacy" language), no states-served list exists anywhere on the site, and no public Terms of Service page could be found at all — an unusual gap for a company its own FAQ describes as serving 250,000+ patients. Separately, FDA issued DirectMeds.com, Inc. a warning letter (MARCS-CMS #716822, September 9, 2025) over marketing language equating compounded GLP-1s to FDA-approved drugs; no close-out letter was found as of this review. And the site's own blog is broken in a way worth naming directly: every article URL checked — including one titled "Meet the Pharmacy," which might otherwise have named a compounding partner — serves the identical, unrelated "shift work" post regardless of slug.

Direct Meds appears on our sermorelin provider ranking, our tirzepatide provider ranking and our semaglutide provider ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You want a single, real, flat monthly price stated directly on the product page, for tirzepatide, semaglutide, or sermorelin, with no quiz or account needed to see it.
  • You've read FDA's own warning letter and are satisfied the specific flagged marketing language no longer determines your decision.

Look elsewhere if

  • You want a stated pharmacy name or a 503A/503B regulatory category — Direct Meds names neither anywhere on the site.
  • You want to confirm your state is served before starting an intake — no states list is published anywhere we could find.
  • You want to read the company's own Terms of Service before signing up — none could be located at any common path on the live site.
  • An open FDA warning letter over how a company marketed compounded GLP-1s is a hard line for you, regardless of what has since changed.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what Direct Meds bundles in, and what it does not.

Clinician consult

Included; a licensed provider reviews the intake before any…

prescription, per its own How It Works page.

Bloodwork / labs

Not stated on the pages checked.

Follow-ups and dose changes

Included

— its own product pages and FAQ state every patient is paired with a dedicated licensed nurse "for the full duration of treatment."

Human support

A dedicated licensed nurse is stated directly and repeatedly

No dietitian or structured coaching program is named anywhere on the pages checked.

Injection supplies

Not itemized on the pages checked.

Shipping

"Fast, discreet delivery" with tracking is stated directly; a…

1-2 business day ship window is stated on multiple pages.

Who fills it, and who's watching

The pharmacy

No pharmacy is named anywhere on the pages checked (homepage, all three product pages, FAQ). Its own FAQ states only that it works with "fully licensed pharmacies" and that prescriptions are "compounded at a certified U.S. pharmacy" — generic language, no name, no 503A/503B category stated.

Oversight

Included; a licensed provider reviews the intake before any prescription, per its own How It Works page. Included — its own product pages and FAQ state every patient is paired with a dedicated licensed nurse "for the full duration of treatment."

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.

Where you can get it

No states-served list or exclusion list was found anywhere on the pages checked. No public Terms of Service page exists at any common path on the live site, where such a list might otherwise appear.

The honest cons

The part they would rather you skipped

FDA issued DirectMeds.com, Inc. a warning letter (MARCS-CMS #716822, September 9, 2025) citing marketing claims that equated compounded semaglutide/tirzepatide to FDA-approved products — "Compounded drug products are not FDA-approved. Your claims imply that your products are the same as an FDA-approved product when they are not," specifically over language including "Compounded semaglutide contains the same active ingredient as branded semaglutide." No FDA close-out letter was found as of this review (2026-08-03), roughly eleven months after the letter's date — the same class of finding already disclosed for several peers on this roster, not a disqualifying one on its own, but one that stays on the record here with its date.

  • No pharmacy is named anywhere on the site, and no 503A/503B regulatory category is stated for any product.
  • No states-served list is published anywhere we could find.
  • No public Terms of Service page exists at any common path on the live site — a real, unusual gap for a company its own FAQ describes as serving 250,000+ patients.
  • The site's own blog is broken: every article URL checked serves the identical, unrelated post regardless of slug, including one titled "Meet the Pharmacy" that might otherwise have named a compounding partner.

None of this is unique to Direct Meds — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Facts on this page reflect Direct Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Direct Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.